Lyophilised hMG versus rFSH in women with unexplained infertility undergoing a controlled ovarian stimulation with intrauterine insemination: a prospective, randomised study

References

• Quass A, Dokras A. Diagnosis and treatment of unexplained infertility. Rev Obstet Gynecol 2008;1:69–76.
   Google Scholar
• The Practice Committee of the American Society for Reproductive Medicine, authors for unexplained infertility. Fertil Steril 2006;86(5 suppl):S111–S114.
   Google Scholar
• Verhulst SM, Cohlen BJ, Hughes E, Te Velde E, Heineman MJ. Intra-uterine insemination for unexplained infertility. Cochrane Database Syst Rev 2006;18:CD001838.
   Google Scholar
• Daya S. Updated meta-analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction. Fertil Steril 2002;77:711–714.
   PubMed Web of Science ®Google Scholar
• van Welly M, Bayram N, van der Veen F. Recombinant FSH in alternative doses or versus urinary gonadotrophins for ovulation induction in subfertility associated with polycystic ovary syndome: a systematic review based on a Cochrane review. Hum Reprod 2003;18:1143–1149.
   Google Scholar
• World Health Organization, Laboratory manual for the examination of human semen and semen-cervical mucus interaction. 3rd ed. New York: Cambridge University Press; 1993. pp 3–27.
   Google Scholar
• Kruger TF, Menkveld R, Stander FS, Lombard CJ, Van der Merwe JP, van Zyl JA, Smith K. Sperm morphologic features as a prognostic factor in in vitro fertilization. Fertil Steril 1986;46:1118–1123.
   PubMed Web of Science ®Google Scholar
• Demirol A, Gürgan T. Comparison of different gonadotropin preparations in intrauterine insemination cycles for the treatment of unexplained infertility: a prospective, randomized study. Hum Reprod 2007;22:97–100.
   PubMedGoogle Scholar
• Erdem M, Erdem A, Güler I, Atmaca S. Role of antral follicle count in controlled ovarian hyperstimulation and intrauterine insemination cycles in patients with unexplained infertility. Fertil Steril 2008;90:360–366.
   PubMed Web of Science ®Google Scholar
• Platteau P, Andersen AN, Balen A, Devroey P, Sorensen P, Helmgaard L, Helmgaard L, Arce JC for the Menopur Ovulation Induction (MOI) study group. Similar ovulation rates, but different development with highly purified menotrophin compared with recombinant FSH in WHO Group II anovulatory infertility:a randomized controlled study. Hum Reprod 2006;21:1798–1804.
   PubMed Web of Science ®Google Scholar
• Loumaye E, Engrand P, Shoham Z, Hillier SG, Baird DT. Clinical evidence for an LH “ceiling” effect induced by administration of recombinant human LH during the late follicular phase of stimulated cycles in World Health Organization type I and type II anovulation. Hum Reprod 2003;18:314–322.
   PubMed Web of Science ®Google Scholar
• Al-Inany H, Aboulghar M, Mansour R, Serour G. Meta-analysis of recombinant versus urinary – derived FSH:an update. Hum Reprod 2003;18:305–313.
   PubMed Web of Science ®Google Scholar
• van Wely M, Westergaard LG, Bossuyt PMM, van der Veen F. Effectiveness of human menopausal gonadotropin versus recombinant follicle stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles:a meta-analysis. Fertil Steril 2003;80:1086–1093.
   PubMed Web of Science ®Google Scholar
• Coomarasamy A, Afnan M, Cheema D, van der Veen F, Bossuyt PMM, van Wely M. Urinary hMG versus recombinant FSH for controlled ovarian hyperstimulation following and agonist long down-regulation protocol in IVF or ICSI treatment: a systematic review and meta-analysis. Hum Reprod 2008;23:310–315.
   PubMed Web of Science ®Google Scholar
• Andersen AN, Devroey P, Arce J-C, for the MERIT Group. Clinical outcome following stimulation with highyl purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. Hum Reprod 2006;21:3217–3227.
   PubMed Web of Science ®Google Scholar
• Selman HA, De Santo M, Sterzik K, Coccia E, El Danasouri I. Effect of highly purified urinary follicle-stimulating hormone on oocyte and embryo quality. Fertil Steril 2002;78:1061–1067.
   PubMed Web of Science ®Google Scholar
• Hompes PGA, Broekmans FJ, Hoozemans DA, Schats R for the FIRM group. Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulatinf hormone in first cycle in vitro fertilization-intracytoplasmic sperm injection patients. Fertil Steril 2008;89:1685–1693.
   PubMed Web of Science ®Google Scholar
• Mohamed MA, Sbracia M, Pacchiarotti A, Micara G, Linari A, Tranquilli D, Espinola SM, Aragona C. Urinary follicle-stimulating hormone (FSH) is more effective than recombinant FSH in older women in a controlled randomized study. Fertil Steril 2006;85:1398–1403.
   PubMed Web of Science ®Google Scholar
• Werbrouck E, Spiessens C, Mouleman C, D'Hooghe T. No difference in cycle pregnancy rate and in cumulative live-birth rate between women with surgically treated minimal to mild endometriosis and women with unexplained infertility after controlled ovarian hyperstimulation and intrauterine insemination. Fertil Steril 2006;86:566–571.
   PubMed Web of Science ®Google Scholar
• Merviel P, Heraud MH, Grenier N, Lourdel E, Sanguinet P, Copin H. Predictive factors for pregnancy after intrauterine insemination (IUI): an analysis of 1038 cycles and a review of literature. Fertil Steril 2010;93:79–88.
   PubMed Web of Science ®Google Scholar
• Aboulghar MA, Mansour RT, Serour GI, Al-Inany HG. Diagnosis and management of unexplained infertility: an update. Arch Gynecol Obstet 2003;267:177–88.
   PubMedGoogle Scholar
• Costello MF, Hughes GJ, Garrett DK, Steigrad SJ, Ekangaki A. Prognostic value of baseline serum oestradiol in controlled ovarian hyperstimulation of women with unexplained infertility. Aust N Z J Obstet Gynaecol 2001;41:69–74.
   Google Scholar
• Goverde AJ, McDonnell J, Schats R, Vermeiden JP, Homburg R, Lambalk CB. Ovarian response to standard gonadotrophin stimulation for IVF is decreased not only in older but also in younger women in couples with idiopathic or male subfertility. Hum Reprod 2005;20:1573–1577.
   PubMedGoogle Scholar
• Crosignani PG, Somigliana E; Intrauterine Insemination Study Group. Effect of GnRH antagonists in FSH mildly stimulated intrauterine insemination cycles: a multicentre randomized trial. Hum Reprod 2007;22:500–505.
   PubMed Web of Science ®Google Scholar
• Dankert T, Kremer JA, Cohlen BJ, Hamilton CJ, Pasker-de Jong PC, Straatman H, van Dop PA. A randomized clinical trial of clomiphene citrate versus low dose recombinant FSH for ovarian hyperstimulation in intrauterine insemination cycles for unexplained and male subfertility. Hum Reprod 2007;22:792–797.
   PubMedGoogle Scholar
• Farhi J, Ben-Haroush A, Lande Y, Fish B. Role of treatment with ovarian hyperstimulation and intrauterine insemination in women with unilateral tubal occlusion diagnosed by hysterosalpingography. Fertil Streil 2007;88:396–400.
   PubMedGoogle Scholar
• Custers IM, Steures P, Hompes P, Flierman P, van Kasteren Y, van Dop PA, van der Veen F, Mol BW. Intrauterine insemination: how many cycles should we perform? Hum Reprod 23:885–888.
   Google Scholar